Announcements Trials
Browse Landscape

Phase

Phase NA 1

Status

Completed 4Unknown 2Recruiting 2Withdrawn 1Terminated 1Not yet recruiting 1

Sponsor Class

OTHER 2

Study Type

Observational 1Interventional 1

Sponsor

Cancer Type

Breast 5Head & Neck 4Gynecologic 4Dermatologic 2Tumor-Agnostic 1Genitourinary 1Gastrointestinal 1

Conditions

Penile Neoplasms 1Mouth Neoplasms 1Melanoma 1Eccrine Porocarcinoma 1Carcinoma, Merkel Cell 1

Interventions

pembrolizumab 65Nivolumab 58Ipilimumab 32Cyclophosphamide 22Specimen Handling 16Magnetic Resonance Spectroscopy 15Biopsy 15relatlimab 13cemiplimab 13fludarabine 12Opdualag 12binimetinib 10Blood Specimen Collection 10aldesleukin 9Radiosurgery 9encorafenib 8Interleukin-2 8atezolizumab 7Immunotherapy 7tebentafusp 6mogamulizumab 6fludarabine phosphate 6Temozolomide 6Surgical Procedures, Operative 6Paclitaxel 6Immunoglobulin G 6CTLA-4 Antigen 6Radiotherapy 5Disulfides 5Bevacizumab 5

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

2 trials
RecentStart dateEnrollment
Recruiting × Sentinel Lymph Node Biopsy × Dermatologic × Clear all
NCT06666634 2024-10-30

NANOSCAN

The Netherlands Cancer Institute

Phase NA Recruiting
29 enrolled
DermatologicGenitourinaryHead & Neck

Melanoma, Mouth Neoplasms, Penile Neoplasms

NCT05797415 2024-10-01

BLS

Fondazione Policlinico Universitario Agostino Gemelli IRCCS

Recruiting
25 enrolled
Dermatologic

Carcinoma, Merkel Cell, Eccrine Porocarcinoma

Data powered by HemOnc (CC BY 4.0) Colophon âš¡